Next Article in Journal
The Biochemical Basis of Hydroxymethylglutaryl-CoA Reductase Inhibitors as Neuroprotective Agents in Aneurysmal Subarachnoid Hemorrhage
Next Article in Special Issue
Allosteric Inhibitors of NMDA Receptor Functions
Previous Article in Journal
Beneficial Effects of Tianeptine on Hippocampus-Dependent Long-Term Memory and Stress-Induced Alterations of Brain Structure and Function
Previous Article in Special Issue
Allosteric Modulation of Muscarinic Acetylcholine Receptors
Pharmaceuticals 2010, 3(10), 3167-3185; doi:10.3390/ph3103167
Article

Dual Allosteric Effect in Glycine/NMDA Receptor Antagonism: A Comparative QSAR Approach

*  and
Received: 13 August 2010; Accepted: 25 September 2010 / Published: 11 October 2010
(This article belongs to the Special Issue Allosteric Modulation)
View Full-Text   |   Download PDF [395 KB, updated 12 October 2010; original version uploaded 11 October 2010]   |   Browse Figure
Abstract: A comparative Hantzsch type QSAR study was conducted using multiple regression analysis on various sets of quinoxalines, quinoxalin-4-ones, quinazoline-2-carboxylates, 4-hydroxyquinolin-2(1H)-ones, 2-carboxytetrahydroquinolines, phenyl-hydroxy-quinolones, nitroquinolones and 4-substituted-3-phenylquinolin-2(1H)-ones as selective glycine/NMDA site antagonists. Ten statistically validated equations were developed, which indicated the importance of CMR, Verloop’s sterimol L1 and ClogP parameters in contributing towards biological activity. Interestingly, normal and inverse parabolic relationships were found with CMR in different series, indicating a dual allosteric binding mode in glycine/NMDA antagonism. Equations reveal an optimum CMR of 10 ± 10% is required for good potency of antagonists. Other equations indicate the presence of anionic functionality at 4-position of quinoline/quinolone ring system is not absolutely required for effective binding. The observations are laterally validated and in accordance with previous studies.
Keywords: allosterism; comparative QSAR; glycine/NMDA; CMR; quinoxalines allosterism; comparative QSAR; glycine/NMDA; CMR; quinoxalines
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Sharma, M.; Gupta, V.B. Dual Allosteric Effect in Glycine/NMDA Receptor Antagonism: A Comparative QSAR Approach. Pharmaceuticals 2010, 3, 3167-3185.

AMA Style

Sharma M, Gupta VB. Dual Allosteric Effect in Glycine/NMDA Receptor Antagonism: A Comparative QSAR Approach. Pharmaceuticals. 2010; 3(10):3167-3185.

Chicago/Turabian Style

Sharma, Manish; Gupta, Vipin B. 2010. "Dual Allosteric Effect in Glycine/NMDA Receptor Antagonism: A Comparative QSAR Approach." Pharmaceuticals 3, no. 10: 3167-3185.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert